FDA Could Authorize Pfizer’s COVID Booster Shot for Ages 5 to 11 on Tuesday
U.S. health regulators are expected to authorize a booster shot of Pfizer/BioNTech’s COVID-19 vaccine for children aged 5 to 11…
Biden Seeks $10B More for COVID, Despite Billion Vaccines Unused
President Joe Biden is pressing lawmakers to release $10 billion in new COVID funding while potentially half of the two…
Researchers Say Evidence Paxlovid Effective Against Long COVID, Trials Warranted
Additional reports of patients with long COVID who were helped by Pfizer Inc’s oral antiviral treatment Paxlovid offer fresh impetus…
Pfizer: COVID Pill Paxlovid Fails to Prevent Infection of Household Members
Pfizer Inc on Friday said a large trial found that its COVID-19 oral antiviral treatment Paxlovid was not effective at…
FDA Will Review Pfizer, Moderna Requests for COVID Vaccines in Young Kids in June
An advisory panel of experts to the U.S. drug regulator will meet in June to review requests from Pfizer Inc…
Pfizer Seeks Authorization of COVID-19 Booster Shot for Ages 5 to 11
Pfizer Inc and its partner BioNTech SE said on Tuesday that they had submitted an application to the U.S. health…
COVID Pill Paxlovid Demand Lags Due to Complications
Worldwide demand for Pfizer Inc’s oral COVID-19 antiviral treatment Paxlovid has been unexpectedly light due to complicated eligibility requirements, reduced…
Pfizer to Get $5 Billion From COVID Aid Bill
Pfizer is likely to receive almost $5 billion from a $10 billion pandemic funding bill being considered by lawmakers, Bloomberg reports.…
Pfizer/BioNTech COVID Vaccine Prevents Pediatric Hospitalization By Up to 93 Percent: Study
Children ages 5 to 11 who received the Pfizer/BioNTech COVID-19 vaccine were 68% less likely to be hospitalized during the…
FDA OKs Another Pfizer/Moderna COVID Booster for 50 & Up
U.S. regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection…